logo

For the Inventor, By the Inventor

Houston, TX, United States of America

Robert G Kilbourn

This inventor holds 15 USPTO granted patents, primarily in Nitric Oxide Inhibition. Top assignees: The University of Texas System, Cornell University, Duke University. Active years: 1991-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert G Kilbourn. Retrieved from https://idiyas.com/inventor/robert-g-kilbourn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 15

% Patents Active = 100.0

Average Co-Inventor Count = 3.1

ph-index = 7

Forward Citations = 245(Granted Patents)


Location History:

  • Naperville, IL (US) (1998)
  • Houston, TX (US) (1991 - 2002)

Company Filing History:

goldMedal13 out of 5,646 
 
The University of Texas System
 patents
silverMedal6 out of 2,956 
 
Cornell University
 patents
bronzeMedal5 out of 2,089 
 
Duke University
 patents
4. 4 out of 11 
 
Apex Bioscience, Inc.
 patents
5. 1 out of 8,608 
 
Massachusetts Institute of Technology
 patents
6. 1 out of 1 
 
Strohtech, Inc.
 patent
7. 1 out of 834,659 
Other
 patents
where one patent can have more than one assignee

Years Active: 1991-2002

Loading Chart...
Areas of Expertise:
Nitric Oxide
Hypotension
Septic Shock
Iron Hemoprotein
Cardiotonic Drugs
Arginine Antagonists
Pathogenic Syndromes
Parenteral Formulations
Anti-Endotoxin
Interleukin-1
Pressor Agents
Amino Acid Formulations
15 patents (USPTO):Explore Patents
1. 6350729 - Inhibition of nitric oxide-mediated hypotension and septic shock with iron-containing hemoprotein (2002-02-26),
2. 6103690 - Prevention or inhibition of pathogenic syndromes caused by nitric oxide (2000-08-15),
3. 5900403 - Use of iron hemoprotein for treating pathogenic syndrome caused by (1999-05-04),
4. 5776979 - Method of use of cardiotonic drugs and inhibitors of nitric oxide (1998-07-07),
5. 5770623 - Argine antagonists for inhibition of systemic hypotension associated (1998-06-23),
6. 5674836 - Treatment of septic shock with iron-containing hemoprotein (1997-10-07),
7. 5534545 - Parenteral amino acid formulations for the inhibition of systemic (1996-07-09),
8. 5480866 - Hemoproteins for inhibition of nitric oxide-mediated hypotension and (1996-01-02),
9. 5374651 - Methods and compositions for the treatment of hypotension with arginine (1994-12-20),
10. 5334380 - Anti-endotoxin, interleukin-1 receptor antagonist and anti-tumor (1994-08-02),
11. 5312835 - Use of cardiotonic drugs and inhibitors of nitric oxide synthesis to (1994-05-17),
12. 5296466 - Inhibition of nitric oxide-mediated hypotension and septic shock with (1994-03-22),
13. 5286739 - Parenteral formulations for the inhibition of systemic hypotension (1994-02-15),
14. 5216025 - Nitric oxide synthesis inhibitors for potentiating the action of pressor (1993-06-01),
15. 5028627 - Method of using arginine derivatives to inhibit systemic hypotension (1991-07-02),

Title: Inventor Spotlight: Robert G Kilbourn

Introduction

Robert G Kilbourn, an inventive mind hailing from Houston, Texas, has made significant contributions to the fields of biomedicine and pharmacology. With a remarkable portfolio of 15 patents, Kilbourn's innovations primarily focus on addressing critical health challenges, particularly those related to nitric oxide production and its physiological impacts.

Latest Patents

Kilbourn's latest patents include innovative methods for managing serious medical conditions. The noteworthy invention, "Inhibition of nitric oxide-mediated hypotension and septic shock with iron-containing hemoprotein," outlines a method aimed at treating animals affected by systemic hypotension due to increased nitric oxide levels, typically induced by biological response modifiers such as cytokines and endotoxins. He also holds a patent for "Prevention or inhibition of pathogenic syndromes caused by nitric oxide," which echoes similar therapeutic approaches for handling the physiological challenges associated with septic shock.

Career Highlights

Throughout his illustrious career, Robert G Kilbourn has been associated with esteemed organizations such as the University of Texas System and Cornell Research Foundation Inc. His work there has not only contributed to his personal accolades but has also advanced medical science, providing essential insights and methodologies for treating complex health issues.

Collaborations

In his professional journey, Kilbourn has collaborated with prominent figures in research, including Steven S Gross and Owen W Griffith. These partnerships have fostered an environment ripe for innovation and have enabled the development of groundbreaking solutions in the biomedical sector.

Conclusion

Robert G Kilbourn's contributions to inventions and medical research highlight the vital role inventors play in enhancing healthcare. With his consistent focus on addressing pressing medical conditions through innovative patents, Kilbourn exemplifies the spirit of invention and dedication to improving lives through science and technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…